Table of Contents
The market for injectable generics has been through a period of consolidation over the last few years as the leading companies have increased their presence through acquisition. The major players include Hospira, Sandoz (Novartis), Hikma Pharmaceuticals, Fresenius Kabi and Teva Pharmaceutical Industries. But interest in generic injectables has not been limited to established generic companies, as pharmaceutical majors like Pfizer have also become...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Amrita
+1 718 303 2019
World demand to increase 6.4% annually through 2017 World enzyme demand is forecast to rise 6.4 percent per annum to $6.9 billion in 2017. Increasing per capita incomes in developing countries will help ...
Biosimilar Index answers your questions, such as... - There are 15 biosimilar and non-comparable biologic (NCB) versions of bevacizumab (Avastin; Roche) in clinical development; with the Biosimilar Index ...
Membrane technology is widely used in various development phases of pharmaceutical, biopharmaceutical and life sciences industries. Membrane technology includes membrane applications from laboratory drug ...
... As a cand to be used in a subunit vaccine against swine erysipelas (imada et al. 1999; Kitajima et al. 2000), Replacing the cellular vaccines in use. The production of recombinant antigenic proteins ...
... Konstantinov kb, yoshida t: dielectric measurement to monitor the growth and the physiological states of biological cells. bioprocess engineering 1994, 11:213 222. 40. Luli gw, strohl wr: comparison of growth ...
Reportlinker.com © Copyright 2014. All rights reserved.